FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to oncohematology, and applies to detection of prognostic molecular genetic criteria for primary refractory multiple myeloma (MM) at the disease onset. The method for predicting the primary refractory form of MM includes isolating genomic DNA from leukocytes of the peripheral venous blood of the patients prior to beginning first-line induction therapy, genotyping the IL10 gene polymorphism at the -1082 mutation point, estimating the distribution of the identified alleles and genotypes, analysing the response to therapy throughout the entire observation period. If a mutant allele A of the IL10 G1082A gene is detected in a hetero- and homozygous state, a high risk of non-response to induction therapy is predicted.
EFFECT: invention allows to obtain new additional criteria for the aspects of the course of MM in the early stages of the disease before the start of the chemotherapy plan to select risk-adapted methods of treatment.
1 cl, 1 dwg, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF DEVELOPING COVID-19 IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES | 2022 |
|
RU2783422C1 |
METHOD FOR PREDICTING DISEASE-FREE SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2015 |
|
RU2580648C1 |
METHOD FOR PREDICTING THE FLOW OF MULTIPLE MYELOMA | 2005 |
|
RU2282852C1 |
METHOD FOR PROGNOSIS OF MULTIPLE MYEOLOMA COURSE | 2002 |
|
RU2225612C2 |
METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA | 2012 |
|
RU2498313C1 |
METHOD OF DETERMINING THE RISK GROUP FOR PATIENTS WITH MULTIPLE MYELOMA COMPLICATED BY PLASMACYTOMA | 2022 |
|
RU2801094C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING INFECTIOUS COMPLICATIONS IN PATIENTS WITH MALIGNANT LYMPHOPROLIFERATIVE DISEASES AND RECEIVING PROGRAM CHEMOTHERAPY | 2014 |
|
RU2587757C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF TOXIC HEPATITIS AT CHEMOTHERAPY OF MULTIPLE MYELOMA | 2005 |
|
RU2283494C1 |
METHOD FOR PREDICTION OF FORMATION OF CHRONIC LYMPHOTIC LEUKEMIA AND ONSET DEVELOPMENT OF COMBINED COMPLICATIONS | 2011 |
|
RU2458349C1 |
METHOD OF PREDICTING EFFICIENCY OF TREATMENT OF PATIENTS WITH HIGH GRADE NON-HODGKIN LYMPHOMA | 2013 |
|
RU2533816C2 |
Authors
Dates
2021-06-16—Published
2020-08-19—Filed